(PharmaNewsWire.Com, December 21, 2017 ) According to the report Liquid Biopsy, published by Market Data Forecast, the Global market is projected to reach USD 1.75 billion by 2021, at a CAGR of 24.3% from 2016 to 2021.
This technology of liquid biopsy has enormous diagnostic and treatment implications for oncology and it is believed to transform clinical practice. A liquid biopsy, may capture the entire heterogeneity of the disease. This methodology is advantageous over tissue biopsies as monitoring of tumour genomic can be done by taking serial samples.
Global Liquid Biopsy: Drivers & Restraints Liquid biopsies are adopted due to the factors such as tolerability and patient convenience. Tissue biopsies cannot be done for few non-small cell lung cancers and liquid biopsy procedures are replacing tissue diagnosis procedures in such cases. Liquid biopsy research process involves a large amount of money and frequent clinical trials which is acting as a restraint for the market growth.
Global Liquid Biopsy: Overview Factors like tolerability and patient convenience of liquid biopsies are affecting the growth of this market positively. However, other factors such as large amount of money and frequent clinical trials are restraining the growth of this market. CTCs (Circulating Tumour cells), the first such entities on the liquid biopsy scene, have accounted for a large share in the market. Cancer institute is the largest end user segment in terms of revenues and is expected to create substantial opportunity in global liquid biopsy market over the forecast period.
Global Liquid Biopsy: Region-wise Outlook The market for Liquid Biopsy in Global region is divided based on geography into North America, Europe, Asia Pacific, Middle East and Africa and Latin America regions. All major action in the field of liquid biopsy is expected to emerge from North America and Europe region over the forecast period. However, increasing funding for private public partnerships in field of cancer research is expected to fuel the Asia-Pacific Market.
Key Questions Answered What is the current and future Liquid Biopsy outlook in Global market? What trends are affecting the Global market? What is the competitive landscape and market share of major players in the Liquid Biopsy space in Global market? What are the key, high growth markets that Liquid Biopsy manufacturers should expand into? Which market segments are growing the fastest? What are the unmet needs with the Liquid Biopsy currently on the market? How will emerging technologies fulfil these unmet needs? What is physician perception and market outlook of Liquid Biopsy? What are the challenges and barriers that have hindered widespread adoption of Liquid Biopsy?
Global Liquid Biopsy: Key Players Some of the key players influencing the market dynamics Philips Healthcare, Siemens Healthcare, Varian Medical Systems, Shimadzu Corporation, GE Healthcare, Shimadzu Corporation, Identafi, Velscope VX, AdDent Inc.
Reasons to buy Global Liquid Biopsy Report: Regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Global Diagnostics Segment:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
